Alphatec Holdings, Inc. reported a 54% increase in total revenue, reaching $109 million for Q1 2023. Surgical revenue grew by 55%, and EOS revenue reached $15 million. The company's adjusted EBITDA margin improved by 1,080 basis points year-over-year. ATEC is maintaining its full-year 2023 revenue growth expectation of 28% to $450 million and anticipates achieving non-GAAP adjusted EBITDA break-even for the year.
Total revenue grew 54% to $109 million, driven by a 55% increase in surgical revenue.
EOS revenue increased to $15 million.
Adjusted EBITDA margin improved by 1,080 basis points year-over-year.
Surgical volume increased by 40%, and average revenue per procedure increased by 11%.
The Company continues to expect total revenue to grow 28% to $450 million for the fiscal year ended December 31, 2023, in line with expectations shared in conjunction with the release of preliminary first-quarter financial results. This includes surgical revenue growth of approximately 30% and $57 million of EOS revenue. The Company continues to expect to achieve non-GAAP adjusted EBITDA break-even for the full-year 2023.
Analyze how earnings announcements historically affect stock price performance